TED

Clinical trials for TED explained in plain language.

Never miss a new study

Get alerted when new TED trials appear

Sign up with your email to follow new studies for TED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New drug aims to reduce bulging eyes in thyroid disease

Disease control Completed

This Phase 3 trial tests satralizumab, a drug that blocks IL-6, in 131 people with moderate-to-severe thyroid eye disease. The main goal is to see if it reduces eye bulging by at least 2 mm after 24 weeks. Participants receive either satralizumab or placebo injections, and resear…

Matched conditions: TED

Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control

Last updated Aug 02, 2026 00:00 UTC

TED

Get alerted when new TED trials appear

New drug aims to reduce bulging eyes in thyroid disease